+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Asia Pacific 3D Bioprinting Market 2021-2031 by Component, Material, Technology, Application, End User, and Country: Trend Forecast and Growth Opportunity

  • PDF Icon

    Report

  • 129 Pages
  • December 2022
  • Region: Asia Pacific
  • GMD Research
  • ID: 5712789
Asia Pacific 3D Bioprinting market will grow by 21.9% annually with a total addressable market cap of $7,456.1 million over 2022-2031, driven by the increasing prevalence of chronic respiratory and cardiovascular disorders (CVDs) due to the aging population, the rising requirement for regenerative medicines/cancer therapeutics/stem cell solutions, the rising governments and private funding, and the technological advancements such as the development of AI and organ-on-a-chip.

Highlighted with 39 tables and 56 figures, this 130-page report “Asia Pacific 3D Bioprinting Market 2021-2031 by Component (Bioprinters, Bioinks), Material (Living Cells, Hydrogels, Extracellular Matrices), Technology (Inkjet, Laser-assisted, Magnetic, Microextrusion), Application (Research, Clinical), End User (Research Organization, Biopharma Companies, Hospitals), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire Asia Pacific 3D Bioprinting market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:

  • Market Structure
  • Growth Drivers
  • Restraints and Challenges
  • Emerging Product Trends & Market Opportunities
  • Porter’s Fiver Forces
The trend and outlook of Asia Pacific market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify Asia Pacific 3D Bioprinting market in every aspect of the classification from perspectives of Component, Material, Technology, Application, End User, and Country.

Based on Component, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • 3D Bioprinters
  • Bioinks
  • Natural Bioinks
  • Hybrid Bioinks
  • Synthetic Bioinks

Based on Material, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Living Cells
  • Hydrogels
  • Extracellular Matrices
  • Other Material Types

By Technology, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Inkjet 3D Bioprinting
  • Laser-assisted Bioprinting
  • Magnetic 3D Bioprinting
  • Microextrusion Bioprinting
  • Other Technologies

By Application, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

Research Application

  • Drug Research
  • Regenerative Medicine
  • 3D Cell Culture

Clinical Application

  • Skin
  • Bone and Cartilage
  • Blood Vessels
  • Other Clinical Applications

By End User, the Asia Pacific market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.

  • Research Organization & Academic Institutes
  • Biopharmaceutical Companies
  • Hospitals
  • Other End Users

Geographically, the following national/local markets are fully investigated:

  • Japan
  • China
  • South Korea
  • Australia
  • India
  • Rest of APAC (further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Material and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.

Selected Key Players:

  • 3D Bio-printing Solutions
  • 3D Systems Inc.
  • 3DBio Therapeutics
  • Advanced Solutions Life Sciences LLC (ASI)
  • Aspect Biosystems Ltd.
  • Bico Group AB
  • Brinter
  • Cellink AB
  • CollPlant Biotechnologies Ltd.
  • Cyfuse Biomedical K. K.
  • Digilab Inc.
  • EnvisionTEC GmbH (Desktop Metal Inc.)
  • Foldink Life Science Technologies
  • GeSiM - Gesellschaft für Silizium-Mikrosysteme mbH
  • Inventia Life Science Pty Ltd.
  • Nano3D Biosciences Inc.
  • Organovo Holdings Inc
  • Pandorum Technologies Pvt. Ltd.
  • Poietis
  • Precise Bio
  • Prellis Biologics
  • Regemat 3D S.L.
  • RegenHU SA
  • Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.)
  • ROKIT Healthcare, Inc.
  • Stratasys Ltd
  • TeVido BioDevices, Inc.
  • Vivax Bio, LLC
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
Frequently Asked Questions about the Asian Pacific 3D Bioprinting Market

What is the estimated value of the Asian Pacific 3D Bioprinting Market?

The Asian Pacific 3D Bioprinting Market was estimated to be valued at $215.8 Million in 2021.

What is the growth rate of the Asian Pacific 3D Bioprinting Market?

The growth rate of the Asian Pacific 3D Bioprinting Market is 21.9%, with an estimated value of $1567.8 Million by 2031.

What is the forecasted size of the Asian Pacific 3D Bioprinting Market?

The Asian Pacific 3D Bioprinting Market is estimated to be worth $1567.8 Million by 2031.

Who are the key companies in the Asian Pacific 3D Bioprinting Market?

Key companies in the Asian Pacific 3D Bioprinting Market include 3D Bio, printing Solutions, 3D Systems Inc., 3DBio Therapeutics, Advanced Solutions Life Sciences LLC (ASI), Aspect Biosystems Ltd., Bico Group AB, Brinter and CollPlant Biotechnologies Ltd..

Table of Contents

1 Introduction
1.1 Industry Definition and Research Scope
1.1.1 Industry Definition
1.1.2 Research Scope
1.2 Research Methodology
1.2.1 Overview of Market Research Methodology
1.2.2 Market Assumption
1.2.3 Secondary Data
1.2.4 Primary Data
1.2.5 Data Filtration and Model Design
1.2.6 Market Size/Share Estimation
1.2.7 Research Limitations
1.3 Executive Summary
2 Market Overview and Dynamics
2.1 Market Size and Forecast
2.1.1 Impact of COVID-19 on World Economy
2.1.2 Impact of COVID-19 on the Market
2.2 Major Growth Drivers
2.3 Market Restraints and Challenges
2.4 Emerging Opportunities and Market Trends
2.5 Porter’s Fiver Forces Analysis
3 Segmentation of Asia Pacific Market by Component
3.1 Market Overview by Component
3.2 3D Bioprinters
3.3 Bioinks
4 Segmentation of Asia Pacific Market by Material
4.1 Market Overview by Material
4.2 Living Cells
4.3 Hydrogels
4.4 Extracellular Matrices
4.5 Other Material Types
5 Segmentation of Asia Pacific Market by Technology
5.1 Market Overview by Technology
5.2 Inkjet 3D Bioprinting
5.3 Laser-assisted Bioprinting
5.4 Magnetic 3D Bioprinting
5.5 Microextrusion Bioprinting
5.6 Other Technologies
6 Segmentation of Asia Pacific Market by Application
6.1 Market Overview by Application
6.2 Research Application
6.2.1 Drug Research
6.2.2 Regenerative Medicine
6.2.3 3D Cell Culture
6.3 Clinical Application
6.3.1 Skin
6.3.2 Bone and Cartilage
6.3.3 Blood Vessels
6.3.4 Other Clinical Applications
7 Segmentation of Asia Pacific Market by End User
7.1 Market Overview by End User
7.2 Research Organization & Academic Institutes
7.3 Biopharmaceutical Companies
7.4 Hospitals
7.5 Other End Users
8 Asia-Pacific Market 2021-2031 by Country
8.1 Overview of Asia-Pacific Market
8.2 Japan
8.3 China
8.4 Australia
8.5 India
8.6 South Korea
8.7 Rest of APAC Region
9 Competitive Landscape
9.1 Overview of Key Vendors
9.2 New Product Launch, Partnership, Investment, and M&A
9.3 Company Profiles
  • 3D Bio-printing Solutions
  • 3D Systems Inc.
  • 3DBio Therapeutics
  • Advanced Solutions Life Sciences LLC (ASI)
  • Aspect Biosystems Ltd.
  • Bico Group AB
  • Brinter
  • Cellink AB
  • CollPlant Biotechnologies Ltd.
  • Cyfuse Biomedical K. K.
  • Digilab Inc.
  • EnvisionTEC GmbH (Desktop Metal Inc.)
  • Foldink Life Science Technologies
  • GeSiM - Gesellschaft für Silizium-Mikrosysteme mbH
  • Inventia Life Science Pty Ltd.
  • Nano3D Biosciences Inc.
  • Organovo Holdings Inc
  • Pandorum Technologies Pvt. Ltd.
  • Poietis
  • Precise Bio
  • Prellis Biologics
  • Regemat 3D S.L.
  • RegenHU SA
  • Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.)
  • ROKIT Healthcare, INC.
  • Stratasys Ltd.
  • TeVido BioDevices, Inc.
  • Vivax Bio, LLC
List of Tables
Table 1. Snapshot of Asia Pacific 3D Bioprinting Market in Balanced Perspective, 2021-2031
Table 2. World Economic Outlook, 2021-2031
Table 3. World Economic Outlook, 2021-2023
Table 4. World Health Spending by Region, $ bn, 2013-2020
Table 5. Main Product Trends and Market Opportunities in Asia Pacific 3D Bioprinting Market
Table 6. Asia Pacific 3D Bioprinting Market by Component, 2021-2031, $ mn
Table 7. Main Vendors and 3D Bioprinters on Market
Table 8. Comparison of Types of Bioprinters
Table 9. Asia Pacific 3D Bioprinting Market: Bioinks by Type, 2021-2031, $ mn
Table 10. Main Vendors and 3D Bioinks on Market
Table 11. Asia Pacific 3D Bioprinting Market by Material, 2021-2031, $ mn
Table 12. Asia Pacific 3D Bioprinting Market by Technology, 2021-2031, $ mn
Table 13. Asia Pacific 3D Bioprinting Market by Application, 2021-2031, $ mn
Table 14. Asia Pacific 3D Bioprinting Market: Research Application by Type, 2021-2031, $ mn
Table 15. Asia Pacific 3D Bioprinting Market: Clinical Application by Type, 2021-2031, $ mn
Table 16. Asia Pacific 3D Bioprinting Market by End User, 2021-2031, $ mn
Table 17. APAC 3D Bioprinting Market by Country, 2021-2031, $ mn
Table 18. Japan 3D Bioprinting Market by Component, 2021-2031, $ mn
Table 19. Japan 3D Bioprinting Market by Material, 2021-2031, $ mn
Table 20. Japan 3D Bioprinting Market by Application, 2021-2031, $ mn
Table 21. China 3D Bioprinting Market by Component, 2021-2031, $ mn
Table 22. China 3D Bioprinting Market by Material, 2021-2031, $ mn
Table 23. China 3D Bioprinting Market by Application, 2021-2031, $ mn
Table 24. Australia 3D Bioprinting Market by Component, 2021-2031, $ mn
Table 25. Australia 3D Bioprinting Market by Material, 2021-2031, $ mn
Table 26. Australia 3D Bioprinting Market by Application, 2021-2031, $ mn
Table 27. India 3D Bioprinting Market by Component, 2021-2031, $ mn
Table 28. India 3D Bioprinting Market by Material, 2021-2031, $ mn
Table 29. India 3D Bioprinting Market by Application, 2021-2031, $ mn
Table 30. South Korea 3D Bioprinting Market by Component, 2021-2031, $ mn
Table 31. South Korea 3D Bioprinting Market by Material, 2021-2031, $ mn
Table 32. South Korea 3D Bioprinting Market by Application, 2021-2031, $ mn
Table 33. 3D Bioprinting Market in Rest of APAC by Country/Region, 2021-2031, $ mn
Table 34. 3D Bio-printing Solutions: Company Snapshot
Table 35. 3D Bio-printing Solutions: Business Segmentation
Table 36. 3D Bio-printing Solutions: Product Portfolio
List of Figures
Figure 1. Research Method Flow Chart
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation
Figure 3. Asia Pacific Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2021-2031
Figure 4. Asia Pacific 3D Bioprinting Market, 2021-2031, $ mn
Figure 5. Impact of COVID-19 on Business
Figure 6. Primary Drivers and Impact Factors of Asia Pacific 3D Bioprinting Market
Figure 7. Total Asia Pacific Regenerative Medicine Financing, 2018-2021 1H, $ mn
Figure 8. Worldwide Geriatric Population (60 years and above) by Regions, 2015 & 2030, million
Figure 9. World Population 65 and Over, % of Total Population, 1950-2060
Figure 10. Primary Restraints and Impact Factors of Asia Pacific 3D Bioprinting Market
Figure 11. Investment Opportunity Analysis
Figure 12. Porter’s Fiver Forces Analysis of Asia Pacific 3D Bioprinting Market
Figure 13. Breakdown of Asia Pacific 3D Bioprinting Market by Component, 2021-2031, % of Revenue
Figure 14. Asia Pacific Addressable Market Cap in 2022-2031 by Component, Value ($ mn) and Share (%)
Figure 15. Asia Pacific 3D Bioprinting Market by Component: 3D Bioprinters, 2021-2031, $ mn
Figure 16. Asia Pacific 3D Bioprinting Market by Component: Bioinks, 2021-2031, $ mn
Figure 17. Breakdown of Asia Pacific 3D Bioprinting Market by Material, 2021-2031, % of Sales Revenue
Figure 18. Asia Pacific Addressable Market Cap in 2022-2031 by Material, Value ($ mn) and Share (%)
Figure 19. Asia Pacific 3D Bioprinting Market by Material: Living Cells, 2021-2031, $ mn
Figure 20. Asia Pacific 3D Bioprinting Market by Material: Hydrogels, 2021-2031, $ mn
Figure 21. Asia Pacific 3D Bioprinting Market by Material: Extracellular Matrices, 2021-2031, $ mn
Figure 22. Asia Pacific 3D Bioprinting Market by Material: Other Material Types, 2021-2031, $ mn
Figure 23. Breakdown of Asia Pacific 3D Bioprinting Market by Technology, 2021-2031, % of Sales Revenue
Figure 24. Asia Pacific Addressable Market Cap in 2022-2031 by Technology, Value ($ mn) and Share (%)
Figure 25. Asia Pacific 3D Bioprinting Market by Technology: Inkjet 3D Bioprinting, 2021-2031, $ mn
Figure 26. Asia Pacific 3D Bioprinting Market by Technology: Laser-assisted Bioprinting, 2021-2031, $ mn
Figure 27. Asia Pacific 3D Bioprinting Market by Technology: Magnetic 3D Bioprinting, 2021-2031, $ mn
Figure 28. Asia Pacific 3D Bioprinting Market by Technology: Microextrusion Bioprinting, 2021-2031, $ mn
Figure 29. Asia Pacific 3D Bioprinting Market by Technology: Other Technologies, 2021-2031, $ mn
Figure 30. Breakdown of Asia Pacific 3D Bioprinting Market by Application, 2021-2031, % of Revenue
Figure 31. Asia Pacific Addressable Market Cap in 2022-2031 by Application, Value ($ mn) and Share (%)
Figure 32. Asia Pacific 3D Bioprinting Market by Application: Research Application, 2021-2031, $ mn
Figure 33. Asia Pacific 3D Bioprinting Market by Research Application: Drug Research, 2021-2031, $ mn
Figure 34. Asia Pacific 3D Bioprinting Market by Research Application: Regenerative Medicine, 2021-2031, $ mn
Figure 35. Asia Pacific 3D Bioprinting Market by Research Application: 3D Cell Culture, 2021-2031, $ mn
Figure 36. Asia Pacific 3D Bioprinting Market by Application: Clinical Application, 2021-2031, $ mn
Figure 37. Asia Pacific 3D Bioprinting Market by Clinical Application: Skin, 2021-2031, $ mn
Figure 38. Asia Pacific 3D Bioprinting Market by Clinical Application: Bone and Cartilage, 2021-2031, $ mn
Figure 39. Asia Pacific 3D Bioprinting Market by Clinical Application: Blood Vessels, 2021-2031, $ mn
Figure 40. Asia Pacific 3D Bioprinting Market by Clinical Application: Other Clinical Applications, 2021-2031, $ mn
Figure 41. Breakdown of Asia Pacific 3D Bioprinting Market by End User, 2021-2031, % of Revenue
Figure 42. Asia Pacific Addressable Market Cap in 2022-2031 by End User, Value ($ mn) and Share (%)
Figure 43. Asia Pacific 3D Bioprinting Market by End User: Research Organization & Academic Institutes, 2021-2031, $ mn
Figure 44. Asia Pacific 3D Bioprinting Market by End User: Biopharmaceutical Companies, 2021-2031, $ mn
Figure 45. Asia Pacific 3D Bioprinting Market by End User: Hospitals, 2021-2031, $ mn
Figure 46. Asia Pacific 3D Bioprinting Market by End User: Other End Users, 2021-2031, $ mn
Figure 47. Breakdown of APAC 3D Bioprinting Market by Country, 2021 and 2031, % of Revenue
Figure 48. Contribution to APAC 2022-2031 Cumulative Market by Country, Value ($ mn) and Share (%)
Figure 49. 3D Bioprinting Market in Japan, 2021-2031, $ mn
Figure 50. 3D Bioprinting Market in China, 2021-2031, $ mn
Figure 51. 3D Bioprinting Market in Australia, 2021-2031, $ mn
Figure 52. 3D Bioprinting Market in India, 2021-2031, $ mn
Figure 53. 3D Bioprinting Market in South Korea, 2021-2031, $ mn
Figure 54. 3D Bioprinting Market in Rest of APAC, 2021-2031, $ mn
Figure 55. Growth Stage of Asia Pacific 3D Bioprinting Industry over the Forecast Period

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3D Bio-printing Solutions
  • 3D Systems Inc.
  • 3DBio Therapeutics
  • Advanced Solutions Life Sciences LLC (ASI)
  • Aspect Biosystems Ltd.
  • Bico Group AB
  • Brinter
  • Cellink AB
  • CollPlant Biotechnologies Ltd.
  • Cyfuse Biomedical K. K.
  • Digilab Inc.
  • EnvisionTEC GmbH (Desktop Metal Inc.)
  • Foldink Life Science Technologies
  • GeSiM - Gesellschaft für Silizium-Mikrosysteme mbH
  • Inventia Life Science Pty Ltd.
  • Nano3D Biosciences Inc.
  • Organovo Holdings Inc
  • Pandorum Technologies Pvt. Ltd.
  • Poietis
  • Precise Bio
  • Prellis Biologics
  • Regemat 3D S.L.
  • RegenHU SA
  • Regenovo Biotechnology Co. Ltd. (Part of Shining 3D Tech Co., Ltd.)
  • ROKIT Healthcare, INC.
  • Stratasys Ltd.
  • TeVido BioDevices, Inc.
  • Vivax Bio, LLC

Methodology

Loading
LOADING...